tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
QuidelOrtho Corporation Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsQuidelOrtho Corporation Reports Q3 2025 Financial Results
7d ago
QuidelOrtho sees FY25 adjusted EBITDA $585M-$605M
Premium
The Fly
QuidelOrtho sees FY25 adjusted EBITDA $585M-$605M
7d ago
QuidelOrtho sees ‘significant growth opportunities’ outside U.S.
Premium
The Fly
QuidelOrtho sees ‘significant growth opportunities’ outside U.S.
7d ago
QuidelOrtho receives FDA 510(k) clearance for VITROS hs Troponin I Assay
PremiumThe FlyQuidelOrtho receives FDA 510(k) clearance for VITROS hs Troponin I Assay
10d ago
Is QDEL a Buy, Before Earnings?
Premium
Pre-Earnings
Is QDEL a Buy, Before Earnings?
10d ago
QuidelOrtho Hold Rating: Impact of Debt Refinancing and Chinese Market Risks
Premium
Ratings
QuidelOrtho Hold Rating: Impact of Debt Refinancing and Chinese Market Risks
1M ago
Cautious Optimism: QuidelOrtho’s Hold Rating Amid Market Challenges and Margin Growth Potential
PremiumRatingsCautious Optimism: QuidelOrtho’s Hold Rating Amid Market Challenges and Margin Growth Potential
3M ago
QuidelOrtho price target lowered to $55 from $60 at Raymond James
Premium
The Fly
QuidelOrtho price target lowered to $55 from $60 at Raymond James
3M ago
QuidelOrtho price target lowered to $40 from $50 at Citi
Premium
The Fly
QuidelOrtho price target lowered to $40 from $50 at Citi
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100